The U.S. Food and Drug Administration (FDA) has introduced “Elsa,” a generative AI tool designed to enhance the efficiency of its regulatory operations. Elsa's deployment comes nearly a month ahead of ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced the official launch of Elsa, a cutting-edge generative Artificial Intelligence (AI) tool designed to optimize efficiency ...

The U.S. Food and Drug Administration on Monday announced the launch of a new generative AI technology that agency leaders said will help its employees do their jobs more efficiently. The tool, called ...

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. The Food and Drug Administration has ...

Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, ...

The US Food and Drug Administration’s (FDA) new artificial intelligence (AI) assistant, Elsa, has received mixed reviews from agency staff who spoke to Focus. While some staff say the tool has been ...

AI woes continue, and the US Food and Drug Agency (FDA) faces the same problem with "Elsa," their latest generative AI tool, which allegedly hallucinates information and misinterprets real studies.

Why it matters: It was only a matter of time before governments jumped aboard the AI hype train. The US government has a lousy track record when it comes to rolling out tech projects – remember the ...